We have recently identi®ed an unusually large human protein that stimulates guanine nucleotide exchange on ARF1 and Rab proteins (EMBO J 15: 4262 ± 4273, 1996). This protein, designated p532 based on its predicted molecular weight (EMBO J 15: 5738, 1996), contains multiple structural domains including two regions of seven internal repeats highly related to the cell cycle regulator RCC1, a guanine nucleotide exchange factor for the small GTP-binding protein Ran, seven b-repeat domains characteristic of the b subunit of heterotrimeric G proteins, three putative SH3 binding sites, a putative leucine-zipper and a carboxyterminal HECT domain characteristic of E3 ubiquitinprotein ligases. Some of these domains are known to be involved in protein-protein interactions, suggesting the existence of p532-interacting proteins. To identify some of these proteins, we used the carboxy-terminal RCC1-like domain (RLD) of p532 in the yeast two-hybrid system. We report here the isolation of a clone that encodes the last 654 amino acid residues of the clathrin heavy chain. This interaction involves amino acid residues 1315 ± 1557 of the clathrin heavy chain and the carboxy, but not the amino-terminal RLD of p532. p532 has been located in the cytosolic fraction as well as in the Golgi apparatus. The interaction between p532 and clathrin only occurs in the cytosol and is mediated by the formation of an ATP-dependent ternary complex with the heat shock protein, Hsp70. These observations suggest that p532 is involved in membrane transport processes.
Introduction RCC1 (regulator of chromosome condensation) is a gene originally identi®ed as responsible for the premature condensation of chromosomes in a mutant hamster cell line (Nishimoto et al., 1978) . RCC1 encodes a protein of 45 kDa with a rather characteristic structure that consists of seven internal repeats. This protein was subsequently shown to catalyze the guanine nucleotide exchange on Ran, a nuclear GTPbinding protein and a member of the Ras superfamily of small GTPases (Bischo and Ponstingl, 1991) . More recently, RCC1 and Ran have been implicated in nucleocytoplasmic transport (Cheng et al., 1995; Moore and Blobel, 1994; Ren et al., 1995; Schlenstedt et al., 1995) .
Interestingly, the RCC1 protein does not share any structural homology with any of the other known guanine nucleotide exchange factors for Ras-like proteins. However, during the last few years, three genes that contain structural elements highly reminiscent of those present in RCC1 have been identi®ed. D25215 is a gene isolated in a randomized cloning in search of full-length transcripts with a size greater than 2 kb (Nomura et al., 1994) and its function remains to be determined. RPGR (retinitis pigmentosa GTPase regulator) has recently been identi®ed by positional cloning as a locus responsible for X-linked retinitis pigmentosa (Meindl et al., 1996) . Finally, we have identi®ed two structural domains highly related to RCC1 in a giant human protein of 4861 amino acid residues that, at least in vitro, stimulates guanine nucleotide exchange on ARF1 and certain members of the Rab family of small GTPases (Rosa et al., 1996a) . We chose to name this gene as p532 based on the predicted molecular mass of its product (Rosa et al., 1996b) . It should be noted, however, that this locus was erroneously designated as p619 in the original publication (Rosa et al., 1996a) .
The p532 gene ®rst was identi®ed as a component of an as yet uncharacterized oncogene activated during the course of gene transfer assays using NIH3T3 cells as recipients (unpublished observations). Whereas, we do not know whether the p532 sequences present in this human transforming gene play any role in its oncogenic activation, they served as a probe to isolate a series of cDNA clones corresponding to a 15 kb long transcript present in a variety of human cells (see below). Nucleotide sequence analysis of these cDNA clones which encompassed a linear sequence of 15 171 nucleotides revealed a single open reading frame corresponding to a protein of 4861 amino acid residues. This protein displays an array of structural motifs including two RCC1-like domains located at both ends of the molecule, seven b-repeat domains characteristic of the b subunit of heterotrimeric G proteins, three putative SH3 binding sites, seven polar amino-acid rich regions, a putative leucine-zipper and a carboxy-terminal HECT domain characteristic of E3 ubiquitin-protein ligases (Rosa et al., 1996a) .
p532 is expressed ubiquitously in mouse and human tissues and overexpressed in several human tumor cell lines. Subcellular localization experiments show that the p532 protein is localized in the Golgi apparatus, although signi®cant levels of p532 were also observed in the cytoplasm. The localization of p532 in the Golgi was altered by Brefeldin A. Biochemical studies indicated that the carboxy-terminal RCC1-like domain of p532 (RLD-2) binds myristoylated ARF1 and the amino-terminal RCC1-like domain (RLD-1) stimulates guanine nucleotide exchange on ARF1 and certain members of the Rab family of proteins (Rosa et al., 1996a) .
Several of the structural motifs present in p532 have been previously shown to be involved in the formation of heteromolecular complexes, suggesting that protein-protein interactions may regulate its function. Indeed preliminary results have indicated the presence of a 180 kDa p532-binding protein in a variety of human cells (Rosa et al., 1996a) . In order to identify this or other proteins that may interact with p532, we have used the yeast two-hybrid system (Fields and Song, 1989) . In this study, we report that clathrin and Hsp70 speci®cally interact with p532 to form a ternary complex under physiological conditions.
Results

Identi®cation of the clathrin heavy chain as a p532-binding protein
To search for proteins that might interact with p532, we dissected its structural motifs and used them as baits in the yeast two-hybrid system (Fields and Song, 1989) . One of these structural motifs, the RCC1-like domain located at the carboxy-terminus of p532 (RLD-2; residues: 4001 ± 4385) was fused to the Gal4 DNA-binding domain (GBD) of the vector pGBT-9 and this construct, pJLR26, was used as a bait. As the tester strain, we used a YPB2 derivative containing the bait plasmid and the two Gal4-inducible markers, HIS3 and lac Z. This tester strain was retransformed with a HeLa cell cDNA library constructed in the pGAD-GH plasmid, a vector that directs the synthesis of fusion proteins containing HeLa cell polypeptides and the Gal4 transcriptional activation domain (GAD). When a GAD fusion protein interacts with the GBD/RLD-2 fusion protein, functional Gal4 activity is reconstituted leading to histidine prototrophy (HIS3) and bgalactosidase expression (lac Z).
A total of 7610 5 transformants were placed in selective media containing 5 mM 3-amino-1,2,4-triazole (see Materials and methods). Those transformants that showed histidine/tryptophan/leucine prototrophy after 2 weeks of culture were subsequently screened for their ability to produce b-galactosidase using a ®lter lift assay (Bartel et al., 1993) . A single b-gal + colony was isolated. To test whether its phenotype was dependent on its interaction with the GBD/RLD-2 fusion protein, the library-derived plasmid (pJLR28) was selectively recovered by complementation of the leuB6 mutation of the E. coli MH4 strain and used to transform YBP2 cells expressing either the GBD/RLD-2 bait or other related GBD fusion proteins.
As shown in Figure 1 , pJLR28 was capable of activating the GBD/RLD-2 fusion protein. The speci®city of this interaction was illustrated by the lack of activation of a related GBD fusion proteins containing the p532 RLD-1 or RCC1. Proteins known to interact with each other such as SNF1 and SNF4 as well as Raf and Ras were used as positive controls. Moreover, we generated a plasmid, pJLR19, that encoded a GBD/RLD-2 fusion protein carrying two missense mutations. One of these mutations was Ile4285Ser (where 4285 is the amino acid number in the full length p532 protein) which corresponds to a conserved hydrophobic domain present in each of the seven repeats of both RLDs as well as in the RCC1 protein (Rosa et al., 1996a) . This mutant protein failed to interact with pJLR28, suggesting the importance of the seven-repeat structure and providing additional evidence for the speci®city of this interaction.
Sequence analysis revealed that pJLR28 contained a 2974 bp cDNA insert with an open reading frame (ORF) capable of encoding a 654 amino acid long polypeptide whose sequence was identical to residues 1022 to 1675 of the heavy chain of human clathrin (CHC) (GeneBank access: D21260). The CHC sequences present in pJLR28 also contained 1012 bp of a 3' untranslated region. Clathrin is constituted by a heavy and a light chain and functions as a structural component of coated vesicles involved in receptormediated endocytosis and Golgi sorting in eukaryotic cells (Pley and Parham, 1993; Robinson et al., 1996; Schekman and Ocri, 1996) . The ®nding that the carboxyl region of CHC interacts speci®cally with the p532 RLD-2 suggests that p532 may be involved in some aspects of vesicular transport pathways.
Localization of the RLD-2 binding site in the clathrin heavy chain
To identify the speci®c sequences of the CHC involved in the binding to the p532 RLD-2, we generated GSTfusion proteins containing dierent regions of CHC ( Figure 2 , upper panel). These proteins were puri®ed by anity chromatography with glutathione-coated beads and incubated with total cellular lysates of Sf9 insect cells infected with a RLD-2 encoding baculovirus. Their association with RLD-2 was determined by immunoblotting with antibodies against the p532 RLD-2. As illustrated in Figure Figure 1 Speci®c interaction between the clathrin heavy chain (CHC) and the p532 RLD-2 domain in the yeast two-hybrid system. 1 mg of pGBT derivative vector containing the p532 RLD-2, the p532 RLD-1, full-length RCC1 or the p532 RLD-2 mutant was cotransformed into yeast cells (YPB2 strain) with 1 mg of pGAD-GH vector containing a cDNA (pJLR28) encoding residues 1022 to 1675 of CHC. Plasmids containing the yeast SNF4 and SNF1, and the human Raf and Ras proteins were used as positive controls. Four independent transfectants selected by Leu-Trp prototrophy were assayed for b-galactosidase activity . A similar amount of the various GST fusion proteins was present in the blot when it was checked by Coomassie Blue staining (data not shown). Taken together, these results show that residues 1315 ± 1557 present in CHC contain the minimal structure required for the RLD-2 binding. Moreover, these results validate those obtained with the two-hybrid system showing that the p532 RLD-2 and CHC speci®cally interact in vitro.
p532 forms an ATP-dependent complex with clathrin and Hsp70
To analyse the interaction of p532 and clathrin in vivo, we conducted a series of co-immunoprecipitation experiments using MCF-7 cells, a human breast adenocarcinoma cell line that possesses relatively high levels of p532 mRNA (Rosa et al., 1996a) . Cellular extracts were immunoprecipitated with anti-p532 antibodies and the resulting immunocomplexes were fractionated by SDS ± PAGE and subjected to Western blot analysis using anti-p532 ( Figure 3a , left panel) or anti-clathrin ( Figure 3a , center panel) antibodies. As illustrated in Figure 3a , CHC co-immunoprecipitated with the endogenous p532. Preimmune serum (P), used as a negative control, did not give detectable CHC coimmunoprecipitation. As an additional speci®city control, preabsorption of the anti-p532 serum with immunizing antigen completely abolished co-immunoprecipitation of CHC (Figure 3a , lane CA). Similar results were observed in a variety of human (CCD45SK, ME180, K562), monkey (COS), rat (NRK) or dog (MDCK) established cell lines (results not shown) indicating that this association is not restricted to a particular cell line. Previous studies have shown that clathrin can interact with the heat-shock protein Hsp70 (Black et al., 1991) . To determine whether Hsp70 can complex with clathrin and p532, we performed a series of coimmunoprecipitation experiments. As shown in Figure  3a (right panel), immunoprecipitation of cell extracts derived from MCF-7 cells with anti-p532 antibodies resulted in the co-immunoprecipitation of Hsp70 as determined by Western blot analysis of the resulting immunoprecipitates with anti-Hsp70 antibodies. Preabsorption of the anti-p532 serum with immunizing antigen completely abolished the co-immunoprecipitation of Hsp70 ( Figure 3a , lane CA). These results show that p532, clathrin and Hsp70 form a ternary complex in vivo.
Hsp70 is an ATPase whose association with clathrin is ATP-dependent (Black et al., 1991) . To analyse the ATP dependence of the ternary complex between Hsp70, p532 and clathrin, we conducted immunoprecipitation experiments in MCF-7 lysates with anti-p532 antibodies. The resulting immunocomplexes were incubated in the absence or in the presence of physiological concentrations of ATP, and subjected to Western blot analysis with anti-clathrin and anti-Hsp70 antibodies. As illustrated in Figure 3b , addition of ATP at 1 mM concentrations to the p532/clathrin/ Hsp70 complex speci®cally released Hsp70 without aecting the association between p532 and clathrin. These observations indicate that ATP can modulate Hsp70 binding to the p532/clathrin complex.
Cytosolic localization of the p532/clathrin/Hsp70 ternary complex
Clathrin is the major component of the coat of vesicles known as clathrin-coated vesicles (CCV). These CCV are involved in endocytosis and exocytosis (Robinson et al., 1996; Schekman and Orci, 1996) . To examine whether p532 was associated to CCV, CCV were isolated from MCF-7 cells and the presence of p532 was analysed by Western blot using anti-p532 antibodies. As illustrated in Figure 4 , p532 could not be detected in CCV. As control, the same blot was incubated with anti-clathrin antibodies (Figure 4) . Similar results were obtained with CCV derived from bovine brain (data not shown). These results indicate that p532 is not a major constitutive component of CCV.
Previous studies have indicated that p532 is located in two dierent subcellular compartments, the cytosol and the Golgi (Rosa et al., 1996a) . To examine whether the association of p532 with clathrin and Hsp70 is constitutive or restricted to certain subcellular compartments, we conducted subcellular fractionation experiments (see Materials and methods). Subcellular fractions derived from MCF-7 cells were analysed directly by Western blot with anti-clathrin and anti- 7) . The resulting complexes were fractionated by SDS ± PAGE and subjected to Western blot (WB) analysis using anti-p532 antibodies. The migration of RLD-2 is indicated by an arrow. Molecular weight markers are indicated on the left Hsp70 antibodies (Figure 5 , right panel). To identify p532, which is not as abundant as clathrin or Hsp70, the same subcellular fractions were immunoprecipitated with anti-p532 antibodies prior to Western blot analysis with anti-p532. These immunocomplexes were also analysed with anti-clathrin and anti-Hsp70 antibodies ( Figure 5, left panel) . As shown in Figure  5 , CHC and Hsp70 present an ubiquitous subcellular distribution (right panel), whereas p532 is restricted to the cytosolic and internal membrane fractions (left . These results show the speci®c nature of the associated between p532, clathrin and Hsp70, and indicate that this association is regulated and restricted to the cytosolic compartment.
Discussion
The present study provides evidence that clathrin, Hsp70 and p532 form stable complexes in intact cells. This conclusion is based on several data: (a) the interaction between the p532 RLD-2 and CHC found with the two-hybrid system; (b) the speci®c association between the residues 1315 ± 1557 of CHC and the p532 RLD-2 shown by binding experiments in vitro; and (c) the association found between endogenous p532, clathrin and Hsp70 in intact cells. This association was restricted to the cytosol and was further supported by the ATP-dependent release of Hsp70 from the immunoprecipitated complexes. The valosin-containing protein (VCP) was identi®ed as an early substrate for tyrosine phosphorylation following T-cell receptor activation (Egerton et al., 1992) . Interestingly, VCP also forms stable cytosolic complexes with clathrin and Hsp70 (Pleasure et al., 1993) . The demonstration that VCP binds to clathrin, its homology to proteins involved in membrane transport, and its similarity to GroEL chaperonins suggest that VCP functions in a subset of clathrinmediated membrane transfer reactions through ATPdependent modulation of protein-protein interactions (Pleasure et al., 1993) . Here, we show that p532 also forms stable complexes with clathrin and Hsp70. Like VCP, only the cytosolic protein is complexed. In addition, p532 is also located in Golgi membranes, where it may bind to ARF1 and stimulate its guanine nucleotide exchange suggesting a role in the activity/ recruitment of ARF1 on Golgi membranes (Rosa et al., 1996a) . The distribution of p532 between Golgi and the cytosol, its co-localization in Golgi with ARF1, and the formation of a cytosolic complex with clathrin and Hsp70 suggest that p532 may also be involved in a subset of clathrin-mediated membrane transfer reactions through ATP-dependent modulation of proteinprotein interactions.
Hsp70 is a molecular chaperone required for posttranslational protein translocation that prevents premature protein folding (Brodsky, 1996; Hendrick and Hartl, 1993) . Interestingly, the RLD-2 domain of p532 that interacts with clathrin also mediates the interaction with ARF1 (Rosa et al., 1996a) suggesting that clathrin, together with Hsp70, may chaperone cytosolic p532. Alternatively, p532 may play a role in the assembly of clathrin in the Golgi through the activation of ARF1. The assembly of clathrin-coated buds in the Golgi requires the recruitment of the heterotetrameric AP-1 adaptor complex, which is dependent on ARF1 (Traub et al., 1993) . The RLD-1 of p532 may stimulate the activation of ARF1 and, thus, ARF1 may increase the association of AP-1 complex and, subsequently, the recruitment of clathrin. Interestingly, the RLD-2 of p532 may interact with ARF1, releasing clathrin and enhancing its recruitment. Additional experiments using a cell-free system could test these hypotheses.
The unusually large size of p532 (4861 amino acid residues) together with its multiple structural motifs (RLD domains, seven b-repeats, three SH3 binding sites, a leucine zipper and a Hect domain), some of which are likely to mediate protein-protein interactions, suggest that p532 may serve as an anchor for other proteins. In support of this hypothesis, we have previously reported the association in vitro and colocalization in vivo of p532 and ARF1 (Rosa et al., 1996a) . We had also detected the association of p532 with a 180 kDa protein (Rosa et al., 1996a) that we have now identi®ed as the clathrin heavy chain using the two-hybrid system. The identi®cation of ARF1 and clathrin as proteins that interact with p532, together with their role in vesicular transport suggest a role for p532 in these processes. Additional studies, using other domains of p532 will be required to identify new p532-binding proteins and to understand the physiological function of these domains. We are currently using the carboxy-terminal HECT domain of p532 in the two-hybrid system in an attempt to ®nd putative ubiquitin-protein ligase substrates. Preliminary results indicate the presence of several proteins that interact with the HECT domain of p532 (unpublished observations). In this regard, it is interesting to notice that the lethal phenotype of clathrin heavy chain-defective yeast can be rescued by overexpression of ubiquitin, thus suggesting a linkage between clathrin and ubiquitination (Nelson and Lemmon, 1993) .
The present study, along with our previous work describing the physical and/or functional interaction of p532 with ARF1 and Rab proteins (Rosa et al., 1996a) , provide an initial model for the role of p532 in membrane tra®cking processes. p532 is distributed between cytosol and Golgi/vesicular-like membrane compartments. Cytosolic p532 is complexed with clathrin and Hsp70 whereas membrane-associated p532 co-localizes with ARF1 and may stimulate its guanine nucleotide exchange. These data suggest an equilibrium of p532 between these compartments similar to that reported for other proteins involved in vesicular transport such as clathrin and ARF1. Additional biochemical studies along with the identi®cation of other p532-binding proteins will shed further light on the physiological role of this giant protein.
Materials and methods
Plasmids RLD01 (residues: 365 ± 794), RLD-2 (residues: 4001 ± 4385) and RLD-2mut (residues: 4001 ± 4385 with D4215N and I4285S mutations) were ampli®ed by PCR from full-length human p532 cDNA (Rosa et al., 1996a) using speci®c oligonucleotides and subcloned into pGTB9 to generate plasmids: pJLR76, pJLR26 and pJLR19, respectively. RCC1 was ampli®ed by PCR from a HeLa cell cDNA library (Stratagene) and subcloned into pGBT9. Plasmids encoding SNF1 and SNF4 proteins and Ras and Raf proteins were described elsewhere (Bartel et al., 1993; Vojtek et al., 1993) . A pGAD-GH derivative encoding residues 1022 ± 1675 of clathrin heavy chain (pJLR28) was isolated from the screening (see below). pGEX-5X-1 (Pharmacia) derivatives including those encoding dierent p532 forms a ternary complex with clathrin and Hsp70 JL Rosa and M Barbacid carboxy-terminal regions of clathrin heavy chain residues: 1022 ± 1164 (pJLR37), 1114 ± 1353 (pJLR38), 1182 ± 1353 (pJLR39), 1315 ± 1557 (pJLR40), 1453 ± 1557 (pJLR41) and 1536 ± 1675 (pJLR42) were generated from pJLR28 by PCRaided ampli®cation using appropriate oligonucleotides.
Library screening
YBP2 cells were transformed to trytophan prototrophy with pJLR26 by the alkaline method (Ito et al., 1983 ) and used to screen a HeLa cDNA library by standard procedures (Bartel et al., 1993) . Positive clone (pJLR28) was sequenced by¯uorescent DNA sequencing (Applied Biosystems). Nucleotide sequences were compiled using Sequencher 2.1 software (Gene Codes Corporation).
Antibodies
Polyclonal rabbit antisera raised against dierent regions of p532 were described elsewhere (Rosa et al., 1996a) . Anti-Clathrin (ICN) and anti-Hsp70 (Oncogene Science) mouse monoclonal antibodies were also used. Rabbit antimouse immunoglobulins were purchased from Dako.
Glutathione S-Transferase fusion proteins and in vitro binding experiments
Glutathione S-Transferase (GST) fusion proteins containing dierent domains of the clathrin heavy chain were puri®ed as previously described (Bustelo et al., 1995) and stored bound to glutathione-Sepharose beads (Pharmacia/ LKB) at 7208C. They were incubated with lysates of insect Sf9 cells infected with a recombinant baculovirus expressing a modi®ed RLD-2 domain containing amino-terminal polyhistidine and carboxy-terminal Flag peptide tags (Rosa et al., 1996a) . Bound proteins were analysed by SDS ± PAGE as described (Bustelo et al., 1995) .
Immunoprecipitation and Western-blot analysis MCF-7 cells were disrupted with lysis buer (10 mM TrisHCl, pH 8.0, 150 mM NaCl, 10% glycerol, 1% Triton X-100, 0.5% deoxycholate, 0.1% SDS, 10 mg/ml aprotinin, 10 mg/ml leupeptin, 5 mg/ml pepstatin and 0.5 mM PMSF) and immunoprecipitated with a rabbit polyclonal antiserum (#410) raised against the p532 RLD-2. Immunoprecipitates were washed three times in washing buer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2 mM EDTA and 0.2% Triton X-100), resolved by SDS ± PAGE (4% acrylamide gel with an 80 : 1 ratio of acrylamide/bis-acrylamide for p532; 8 ± 15% acrylamide gradient gel for clathrin and Hsp70) and subjected to Western blot analysis using either anti-p532 (#417) (1 : 500), anti-clathrin (1 : 50) or antiHsp70 (1 : 1000) antibodies. Filters were developed by autoradiography using [125I]protein A (Amersham).
Subcellular fractionation and isolation of clathrin-coated vesicles
MCF-7 cells were lysed and subcellular fractions were separated and analysed as described elsewhere (Rosa et al., 1996a) . Clathrin-coated vesicles were isolated from MCF-7 cells or bovine brain as described by (Chakrabarti et al., 1993) and (Keen, 1987) , respectively.
